Connect with us

Business

Will McKesson Make Maricann Canada’s Next Unicorn Stock?

Published

on

 

Now you can add McKesson to the list of major corporations taking a stake in the legitimate marijuana industry with a recent deal to partner with medical marijuana grower Maricann (CNQ:MARI).

Suddenly, the formerly quiet grower that didn’t even have a stock market listing until this April is becoming the most talked about company in Canada’s medical marijuana universe.

The McKesson deal is just one of the major events pushing it into the spotlight, but it’s the one that has immediate upside potential.

McKesson, with $199 billion in annual sales, is the largest pharmaceutical distributor in the US and Canada. Its McKesson Canada division controls about 20% of Canada’s pharmacies. Ultimately the Maricann deal, which was announced quietly in August, will make Maricann the exclusive grower to supply medical marijuana products in McKesson’s five retail pharmacy chains.

Maricann Prepares to Take a Big Slice of the Market

Dundee Capital predicts that Canada’s medical marijuana sales will reach $3 billion by 2024.

Maricann is already selling direct to patients. That was a $4 million business last year, when the company first got approval from Health Canada. The company projects sales at $23 billion business next year (2018).

Now, with the McKesson venture, Maricann is preparing to sell product through regular pharmacies as well. This is likely to attract patients who prefer to buy medical marijuana near where they live, just as they do with their other medical supplies. With the two strong distribution channels at its command, you can see why Maricann stands ready to take a sizeable slice of Canada’s medical marijuana market.

The McKesson deal wasn’t the only startling news lately.

This fall, Canaccord Genuity named Maricann as its “Top Pick” among marijuana stocks

In the young marijuana business, a Canaccord blessing is like having angels proclaim its greatness. Canaccord is one of the three most influential investment banks in Canada’s marijuana industry. Its in-depth industry reports are widely read and followed. In the past, Canaccord has thrown its weight behind companies like Canopy Growth, Aurora Cannabis and Aphria—all of which have reached “unicorn” status, as companies with $1 billion or higher market caps.

That the Cannacord “Top Pick” rating came before news of the McKesson deal should give you an idea how strongly industry insider feel about Maricann’s outlook.

The real hint that Maricann was about to join the big leagues, though, came in June.  That was when MJIC added Maricann to both the North American Marijuana Index (35 public companies) and the Canadian Marijuana Index (18 companies). That’s very high profile.

And all this was hardly digested before news broke the next bombshell….

Maricann Is Fast approaching a 10X Canadian Expansion  

Maricann is definitely taking its place among the big growers already.

At present, it is operating from a 46,000 sq. ft. facility in Langton, Ontario that can produce about 2,200 kg of marijuana per year. But this is increasing rapidly.

Maricann is another 800,000 sq. ft. of growing space at that site. At full expansion, the Langton facility will be capable of producing 100,000 kg of marijuana.

The first phase of this expansion should be completed this winter.  That means that within six months, Maricann will be capable of adding another 25,000 kg to its annual production—about 10X what it’s growing now.

All systems are go. On Nov. 8, Health Canada lifted Maricann’s growing limitations at the Ontario operation and the new Maricann license increases its permitted capacity to 6,250,000 grams of marijuana on site at any one time.

This upgrade presents a 480% increase in production capacity for Maricann—above the full extent of the expansion that is currently being built, that is.

Germany Is Maricann’s Differentiator

Maricann stands out from the pack on several counts, but none more than its foray into the European markets.

In Germany, MARI has an option to buy an existing facility near Dresden that it will  convert to an indoor grow house. It’s a huge space—a 1.5 million sq. foot building in excellent condition that was formerly a Cargill meat packing plant.

The new German facility is almost twice as large as the Ontario expansion plans, and it should be ready to use within months.  If Maricann can achieve the same yields per square foot it is getting in Canada, the German operation could add another 47,000 kg to annual production–more than 20X what MARI produced last year.

Germany only recently approved medical marijuana, but there were no German companies ready to produce. Maricann, with its experience will likely be the first approved company to produce medical marijuana in Germany. This is a lead it’s likely to keep, too, because Germany only plans to issue 11 growing licenses. One of them will certainly have Maricann’s name on it.

Maricann Competes Hard on Cost, Too

As it builds out its added capacity, Maricann is perfecting its growing system so that it will be able to position itself as one of Canada’s lowest-cost producers. The company expects it will be able to produce high-grade medical marijuana at just  $1.34 per gram ($38 per ounce).

Even as medical marijuana prices fall, Maricann will easily remain profitable and very capable of undercutting most, if not all, its competitors.

 

Looking Ahead… A New Drug, More Growth, Enormous Value

The McKesson deal, Cannacord’s blessing, approval for more production…. All that should be more than enough to interest any investor, but the news just keeps coming.

In August, Maricann agreed to acquire NanoLeaf Technologies, a biotech that holds a number of licenses for pharmaceuticals and cosmetics. What that brings to MARI is the potential to market the first ever marijuana in a gel cap with verified standard dosages.

Nobody else has that. Maricann expects that the gel caps will be ideal for medical delivery of cannabis oils, which it produces at its Ontario facility.

But perhaps the most compelling reason for investors to load up on Maricann is that this well-financed, strongly growing company is also deeply undervalued. Based on revenues, it is selling at a 50%-60% discount to its marijuana industry peers.  On earnings to economic value basis, it’s at a 47% discount.

Cheap stock, strong growth, and industry respect—there’s a lot to love about Maricann.

Business

Green Growth Brands Inc (OTCMKTS:GGBXF) Reports Revenues Of $12.7 Million In Q1 2020: Retail Sales of Account For Two-Thirds Of Total CBD Sales

Published

on

Green Growth Brands Inc (OTCMKTS:GGBXF) has reported revenues of $12.7 million in Q1 2020. The retail sales of CBD accounted for two-thirds of the total sales. Chief Executive Officer of Green Growth, Peter Horvath, said the team at Green Growth is confident to continue the growth story with the approaching holiday season.

Retail CBD sales

Green Growth is pleased with the topline growth recorded in Q1 and the current results, which shows consistent growth in the future. The retail CBD sales in November accounted for two-thirds of the overall sales reported in the total thirteen weeks of Q1 2020. According to Peter, the company accomplished a significant CBD footprint in a short period. He said the chain of shops, products, and wholesale relationships and growing web businesses strengthens the company’s position as a leader in the CBD industry. Green Growth expects to maintain the same trend in the future.

Highlights of Q1 2020

Green Growth reported Pro-forma revenues of $15.3 million from The+Source Henderson. Its MSO revenues are reported at $7.6 million, an increase of 38% from the previous quarter. The annual revenues from The+Source dispensaries based in Nevada are continuing at $15,000 per Sq. Ft. Green Growth has reported revenues of $5.1 million and expects to post more than $10 million in Q2 2020.

The total number of shops of Green Growth has surged to 139 across thirty-four states by the end of the quarter with the inauguration of eighty-one mall-based CBD shops in Q1 2020. Green Growth currently manages 193 shops. It is fulfilling the white label order ‘Mood’ of American Eagle. As per the performance indications, the company will maintain a partnership with American Eagle.

Green Growth opens 150th store

Green Growth has opened 150th Seventh Sense CBD mall-based shop in Columbus, Ohio. According to the customer database, 20% of its customers indulged in repeat purchases. The company is experiencing repeat purchases every 31 days online.

Green Growth has introduced SMS texting to customers on August 7, 2019. The enrollment to the services has increased considerably in the past 30 days. Seventh Sense will unveil the national media campaign this month, focusing on branded and media partnerships.

Continue Reading

Business

Indiva Ltd (OTCMKTS:NDVAF) Signs A Financing And A White Label Production Agreement With Dycar Pharmaceuticals Ltd: Produces Cannabis Products Under Dycar Brand

Published

on

Indiva Ltd (OTCMKTS:NDVAF) signed a white label manufacturing accord with Dycar Pharmaceutical Ltd. As per the deal, the company will produce high-quality cannabis products under the Dycar brand from its London, Ontario licensed facility. Indiva will also receive financing of up to $4 million from Dycar.

Option to extend the deal

Indiva will repay the debt through its services to Dycar. It has an option to extend the deal for an additional two terms (minimum) at the sole discretion of Dycar. As a result, Indiva will get additional non-dilutive financing of up to $4.5 million.

CEO of Indiva, Niel Marotta, said the company is pleased to rope in a high-quality partner – Dycar into its B2B platform. Both firms share the same vision to deliver high-quality products to satisfy the market needs. He further said the company is excited to work with Dycar and bring innovative products that exceed the consumer and customer expectations.

Funding expected in mid-December 2019

Indiva expects the funding in mid-December 2019 subject to satisfying customary conditions that comprise receiving applicable third-party approvals and executing definitive agreements. The company also expects to receive financing of up to $4 million through unsecured convertible debentures. Each debenture is priced at $1000 and convertible to 5,000 common shares (at $0.20 for each share) of Indiva. The debenture holders will receive an interest of 10% and paid semi-annually (on December 31 and June 30). Issued debentures have a maturity of 36 months from the date of issue.

In Q3 2019, Indiva posted revenues of $185,539. The company received the nod for the distribution of pre-rolls, dry flower, and capsules to the customers in Quebec. It will also offer extraction services as per the accord signed in August 2019 to TerrAscend. Indiva will receive a minimum of 800 kg of dry flower annually from TerrAscend.

Marotta said the company is poised to report significant growth next year. He praised the strengths of his teams and contributions from partners for achieving commercial scale in such a short period. Indiva expects to meet the needs of 90% of the eligible customers by providing high-quality products.

Continue Reading

Business

Health Canada Authorizes Delta 9 Cannabis Inc (OTCMKTS:VRNDF) To Market Edible Cannabis Products, And Cannabis Extracts

Published

on

Health Canada has authorized Delta 9 Cannabis Inc (OTCMKTS:VRNDF) to sell edible cannabis products, cannabis topical, and cannabis extracts. Chief Executive Officer of Delta, John Arbuthnot, said the approval from Health Canada permitting the sale of cannabis products is a milestone for the company.

Sells cannabis extracts on January 5, 2020

Delta has submitted notifications for innovative nine cannabis products to Health Canada on November 5, 2019. The updated processing license received from Health Canada on December 4, 2019, allows Delta to sell cannabis extracts with effective from January 5, 2020. John said the team at Delta worked relentlessly to introduce dried cannabis extracts, disposable vape oil pens, and vaporizable oil cartridges. According to the CEO, the company will begin shipment of cannabis products in early 2020.

Vaporizable cannabis oils

Delta is currently working with Westleaf Inc., with the help of Westleaf Labs LP for the development of disposable vape pens and vaporizable oil cartridges. These innovative products will comprise cannabis terpenes and distilled cannabis oil. Delta will brand these products under the brand names: Blast, Cruise, and Harmony that comprise active cannabinoids in different concentrations. The customers can buy vape products for recreational use in Q1 2020.

Dried sift cannabis products for recreational use

Delta is developing the sapphire line of sift cannabis (dried) products for recreational use. It sifts the blended products and later refines them. The resulting yellow/ brownish fine powder comprises lower levels of low potency plant materials and higher levels of high potency resin glands. It has a potency of over three times that of dried white flower cannabis. The customers can purchase dried sift cannabis products for recreational use in Q1 next year.

Delivers cannabinoids through nanoparticle technology

In Canada, Delta received an exclusive license to produce, and market products developed using Nanosphere Health Sciences Inc’s patented technology. The cannabinoids are delivered through nanoparticle technology of Nanosphere Health. Both companies are engaged in developing the first product to suit the needs of Canadian customers. Delta will produce intranasal products, transdermal viscous gels, and intraoral products using the nanosphere delivery system. It ensures precise dosage, faster results, and high bioavailability.

Delta focused on expanding the Winnipeg facilities in Q3 2019. The expansion helps the company to produce high-quality cannabis products.

Continue Reading

FEATURED STORIES

TRENDING19 hours ago

Terrascend Corp (OTCMKTS:TRSSF) Speaks Out About Its Two Year Term Loan

Post Views: 75 Terrascend Corp (OTCMKTS:TRSSF) has today announced the extension of its credit facility. It has also disclosed that...

TRENDING19 hours ago

Lift & Co Corp (OTCMKTS:LFCOF) To Expand Business Operations In The US

Post Views: 65 Lift & Co Corp (OTCMKTS:LFCOF) is quite pleased about the addition of the adobe advertising capabilities to...

TRENDING19 hours ago

Zelira Therapeutics (OTCMKTS:ZLDAF) Intends To Expand HOPE® Distribution In The US

Post Views: 104 Zelira Therapeutics (OTCMKTS:ZLDAF) has disclosed details about its plant to move its HOPE® Franchise to Louisiana. The...

TRENDING21 hours ago

United Greeneries Ltd Of Harvest One Cannabis Inc (OTCMKTS:HRVOF) Agrees To Provide Royal High And Captain’s Choice Branded Cannabis

Post Views: 93 United Greeneries Ltd, a wholly-owned subsidiary of Harvest One Cannabis Inc (OTCMKTS:HRVOF), has signed a deal to...

TRENDING21 hours ago

Phivida Holdings Inc (OTCMKTS:PHVAF) Reports Significant Black Friday Sales Of $85,000 CAD For Bloomgroove: Phivida Introduces CBD Market Place Online

Post Views: 98 Phivida Holdings Inc (OTCMKTS:PHVAF) has reported robust first black Friday week sales of $85,000 CAD for Bloomgroove,...

TRENDING22 hours ago

Cannabis Strategic Ventures (OTCMKTS:NUGS) Significantly Expands Operational Output: Expects To Post Revenues Of Over $5 Million In 2020

Post Views: 71 Cannabis Strategic Ventures (OTCMKTS:NUGS) has improved operational output considerably in 2019 and expects to post significant revenues...

Whats Hot